STOCK TITAN

Axim Biotechnologies Inc (AXIM) Net Income by Year

AXIM

Axim Biotechnologies Inc reported a net loss of $8.1M in fiscal year 2023. This represents a decrease of 29.1% from the prior fiscal year. Over the trailing 12 months, Q3 FY2023 through Q2 FY2024, the same line adds up to a $4.1M net loss. The table below carries 13 fiscal years, from 2011 to 2023, and the quarters Axim Biotechnologies Inc has filed alongside them.

FY2023 annual
Net Income -$8.1M
YoY -29.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2024, ended Jun 30, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

AXIM Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$4.1M-$8.1M-29.1%-$6.2M+61.1%-$16.0M-150.1%-$6.4M+0.6%-$6.4M+4.5%-$6.8M-62.1%-$4.2M+28.3%-$5.8MN/A-$583K-553.4%-$89K-498.6%-$15K-433.4%-$3K

TTM is the trailing twelve months, Q3 FY2023 through Q2 FY2024, summed from the four most recent quarterly filings.

AXIM Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2410-QQ1'2410-QQ4'2310-QQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-KQ3'2110-Q
Net Income-$2.3M+39.0%-$292K+89.4%-$1.9M$328K+116.1%-$3.7M-204.5%-$2.8M-32.4%N/A-$2.0M+38.2%-$1.2M+68.1%-$2.1M-141.4%-$8.0M-$3.3M-72.7%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Axim Biotechnologies Inc financials

Frequently Asked Questions

What was Axim Biotechnologies Inc's net income in fiscal year 2023?

Axim Biotechnologies Inc reported a net loss of $8.1M in fiscal year 2023.

How fast is Axim Biotechnologies Inc's net income growing?

Axim Biotechnologies Inc (AXIM) net income fell by 29.1% year over year, from -$6.2M to -$8.1M in fiscal year 2023.

What is Axim Biotechnologies Inc's net income over the last twelve months?

Axim Biotechnologies Inc (AXIM) reported a $4.1M net loss over the trailing 12 months, Q3 FY2023 through Q2 FY2024, summed from the four most recent quarterly filings.

Across the 13 fiscal years this page covers, Axim Biotechnologies Inc (AXIM) net income went from -$3K in fiscal year 2011 to -$8.1M in fiscal year 2023.

Axim Biotechnologies Inc (AXIM) reported -$2.3M in net income in Q2 2024. This represents an increase of 39.0% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Axim Biotechnologies Inc (AXIM) reported on that line in every period on record.